文献速递肾小球疾病慢性肾脏病

HLA I类和II类血清型与MPGN及致密沉积病所致终末期肾病的关联

The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
PubMed 文献 · Am J Kidney Dis · 2023-09-20

基于美国USRDS和UNOS数据的病例对照研究,纳入3424例MPGN和263例DDD所致肾衰竭患者,按种族1:15匹配肾供者对照,分析58种HLA血清型。

要点

  • HLA-DR17与MPGN所致ESKD相关(OR 1.55),白人和黑人患者中关联强度相似。
  • 未发现任何HLA血清型与DDD所致ESKD有显著关联。
  • 抗GBM肾炎阳性对照中重现了已知HLA关联,支持方法可靠性。

核心结论

  • HLA-DR17与多种族队列中MPGN所致ESKD相关,白人和黑人患者关联强度相似,提示其在MPGN发病中可能起作用。
  • DDD患者中未观察到HLA关联。

研究设计与样本

  • 病例对照研究,使用USRDS和UNOS数据识别3424例MPGN和263例DDD所致肾衰竭患者,按指定种族1:15匹配肾供者对照。
  • 暴露为58种I类和II类HLA血清型,结局为病例对照状态,采用单变量和多变量逻辑回归分析,并进行Bonferroni校正。

主要发现

  • 任何HLA血清型与DDD均无显著关联。
  • 按指定种族分析显示可比结果。
  • 抗GBM肾炎中重现已知HLA关联。

局限性

  • 依赖HLA血清型而非基因型。
  • 缺乏活检确诊诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Membranoproliferative glomerulonephritis (MPGN), encompassing several distinct diseases, is a rare but significant cause of kidney failure in the United States. The potential etiologies of MPGN are unclear, but prior studies have suggested dysregulation of the alternative complement pathway and, recently, autoimmunity as potential mechanisms driving MPGN pathogenesis. In this study, we examined HLA associations with end-stage kidney disease (ESKD) due to MPGN and dense deposit disease (DDD) in a large racially and ethnically diverse US-based cohort. STUDY DESIGN: Case-control study. SETTING & PARTICIPANTS: Using US Renal Data System (USRDS) and United Network for Organ Sharing (UNOS) data, we identified 3,424 patients with kidney failure due to MPGN and 263 due to DDD. We matched patients to kidney donor controls on designated race and ethnicity in a 1:15 ratio. EXPOSURE: 58 class I and II HLA serotypes. OUTCOME: Case-control status. ANALYTICAL APPROACH: For each disease cohort, univariable and multivariable logistic regression analyses were used to investigate associations between the disease and 58 HLA serotypes. In subgroup analyses, we investigated HLA associations in White and Black patients. We also studied antiglomerular basement membrane (anti-GBM) nephritis as a positive-control outcome. We applied a Bonferroni correction to account for multiple comparisons. RESULTS: Eighteen serotypes were significantly associated with the odds of having MPGN in univariable analyses, with DR17 having the strongest association (odds ratio [OR], 1.55 [95% CI, 1.44-1.68], P=4.33e-28). No significant associations were found between any HLA serotype and DDD. Designated race-specific analyses showed comparable findings. We recapitulated known HLA associations in anti-GBM nephritis. LIMITATIONS: Reliance on HLA serotypes (rather than genotype), lack of biopsy-confirmed diagnoses. CONCLUSIONS: HLA-DR17 is associated with ESKD due to MPGN in a racially and ethnically diverse cohort. The strength of association was similar in White and Black patients, suggesting a role in the pathogenesis of MPGN. No HLA associations were observed in patients with DDD. PLAIN-LANGUAGE SUMMARY: Prior studies have suggested dysregulation of the alternative complement pathway as a potential etiology of membranoproliferative glomerulonephritis (MPGN), but recent evidence from a British White population has implicated an autoimmune mechanism in MPGN pathogenesis. We investigated HLA associations between MPGN and dense deposit disease (DDD) in a large racially and ethnically diverse cohort of patients. We found that HLA-DR17 is associated with end-stage kidney disease (ESKD) due to MPGN in both White and Black patients. By contrast, no significant HLA associations with ESKD due to DDD were identified. These results suggest a role for autoimmunity in some cases of MPGN and highlight differences in the disease etiology of MPGN compared with DDD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Afolabi H, Zhang BM, O'Shaughnessy M, et al. The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease. Am J Kidney Dis. 2023. PMID: 37739026. doi:10.1053/j.ajkd.2023.06.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。